Related Experiment Videos
ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function
Abstract:
Deletion mutants of the viral Harvey ras oncogene were generated by removing different lengths of the gene from either the amino or the carboxyl terminus. The deletion mutants, ras p21 expressed in Escherichia coli, yielded proteins of approximately 8, 10, 12, 14, 17, 18, 19, and 20 kDa. These proteins were utilized to identify epitopes recognized by a series of recently generated monoclonal antibodies as well as some previously reported monoclonal antibodies. Monoclonal antibodies that inhibited GTP binding, a major biochemical activity of the p21 protein, recognized two major regions of the protein. These regions were localized from amino acids 5 to 69 and 107 to 164, respectively, and were separated by another stretch from residues 70 to 106, whose antigenic determinants were not directly involved in GTP binding. Thus, the mapping of epitopes within the p21 molecule recognized by monoclonal antibodies has made it possible to localize important functional regions within the ras p21 molecule.
Insights
Researchers mapped functional regions of the ras p21 protein by analyzing deletion mutants. Monoclonal antibodies targeting GTP binding identified key areas, aiding in understanding ras oncogene function.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- The ras oncogene plays a crucial role in cell signaling and cancer development.
- Understanding the functional domains of the ras p21 protein is essential for targeted therapies.
Purpose of the Study:
- To map the epitopes recognized by monoclonal antibodies on the ras p21 protein.
- To identify functional regions of the ras p21 protein, particularly those involved in GTP binding.
Main Methods:
- Generation of Harvey ras oncogene deletion mutants expressed in Escherichia coli.
- Characterization of mutant proteins using monoclonal antibodies, including those that inhibit GTP binding.
- Localization of antibody-recognized epitopes and functional regions based on amino acid residues.
Main Results:
- Deletion mutants of ras p21 yielded proteins of various molecular weights (8-20 kDa).
- Monoclonal antibodies inhibiting GTP binding recognized epitopes in two major regions: amino acids 5-69 and 107-164.
- A central region (residues 70-106) was identified with antigenic determinants not directly involved in GTP binding.
Conclusions:
- Epitope mapping using monoclonal antibodies successfully localized functional regions within the ras p21 protein.
- The study identified specific regions critical for GTP binding, a key biochemical activity of ras p21.
- This detailed mapping provides a foundation for further research into ras oncogene function and therapeutic strategies.